Leveraging genomic surveillance to enhance elimination strategies for hepatitis C virus

Lancet Microbe. 2022 Dec;3(12):e893-e894. doi: 10.1016/S2666-5247(22)00204-X. Epub 2022 Aug 16.

Author

Damien C Tully¹

Affiliation

¹ Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK. Electronic address: damien.tully@lshtm.ac.uk.

No abstract available

MeSH terms

Antiviral Agents / therapeutic use
Genomics
Hepacivirus* / genetics
Hepatitis C* / genetics
Humans

Substances

Antiviral Agents